SCHEMBL5811735

SCHEMBL5811735

CCC(CC)N1CCc2c(Br)cccc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.41
PARP11 Q9NR21 1/20 0.41
PIM1 P11309 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK5 Q00535 1/20 0.36
ROCK1 Q13464 1/20 0.36
DYRK1A Q13627 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
HTT P42858 1/20 0.36
CYP1B1 Q16678 4/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
GRM5 P41594 3/20 0.35
GRM1 Q13255 2/20 0.35
ACACB O00763 2/20 0.35
CARM1 Q86X55 1/20 0.34
PRMT6 Q96LA8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3000769 0.89 DHPS (0.41) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL5811349 0.84 PARP10 (0.44) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL5808818 0.81 GRM5 (0.40) HTTMEN1MAPTKMT2AGRM5
SCHEMBL5839596 0.81 HTT (0.35) HTTCYP1B1MEN1MAPTKMT2A
SCHEMBL5840128 0.78 HTT (0.56) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL3003306 0.78 HSD11B1 (0.41) PARP10PARP11HTTMEN1KMT2A
SCHEMBL12059947 0.76 ALOX15 (0.43) MEN1MAPTKMT2A
SCHEMBL3005582 0.75 CBLB (0.39) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL5811844 0.75 HTT (0.45) PARP10PARP11PIM1CSNK1A1CDK5
SCHEMBL5839859 0.75 POLB (0.50) PARP10PARP11PIM1CSNK1A1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144894-B2 Sulfonamide bicyclic compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2006-12-05 US disclosed
WO-2006034480-A2 SULFONAMIDE BICYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-03-30 WO disclosed
US-20060063799-A1 Sulfonamide bicyclic compounds BRISTOL-MYERS SQUIBB COMPANY 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063799-A1 Sulfonamide bicyclic compounds APP, BACE1, IAPP PARP10 3549/4885PARP11 2838/4885PIM1 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.